Blog Posts
Breast Cancer
Photo: Depositphotos

Mark Bolton: FAST FORWARD Trial results at ESTRO 2025 – Dose-Response and Toxicity

Mark Bolton, Radiation Oncologist, shared a post on X:

“With long term FAST FORWARD data: dose response here makes no sense; 27 Gy has higher recurrence estimates than 26 Gy
Also more toxic regimen than 15 fractions.”

FAST FORWARD

ESTRO 2025 Live Updates on OncoDaily.

FAST-Forward trial 10-year results from ESTRO 2025: Hypofractionated breast radiotherapy for 1 vs 3 weeks

cancer ESTRO ESTRO 2025 ESTRO25 FAST-Forward trial Mark Bolton OncoDaily Oncology radiation oncology